MCT4 targeted inhibition destroys intracellular pH homeostasis and initiates self-apoptosis of HCC cells (245), and MCT4 inhibitor VB124 enhances T cell infiltration and the potency of anti-PD-1 immunotherapy in HCC mice (226). Here, PDCD1 is linked to hepatocellular carcinoma.